1. Home
  2. HBB vs RLMD Comparison

HBB vs RLMD Comparison

Compare HBB & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

SELL

Current Price

$34.48

Market Cap

418.3M

ML Signal

SELL

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.36

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBB
RLMD
Founded
1904
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.3M
461.9M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
HBB
RLMD
Price
$34.48
$3.36
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $10.75
AVG Volume (30 Days)
76.7K
★ 1.2M
Earning Date
11-04-2026
11-12-2026
Dividend Yield
★ 1.44%
N/A
EPS Growth
N/A
★ 45.28
EPS
★ 2.75
N/A
Revenue
★ $606,852,000.00
$13,070.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.59
★ N/A
Revenue Growth
N/A
★ 154.83
52 Week Low
$13.75
$1.80
52 Week High
$39.99
$8.00

Technical Indicators

Market Signals
Indicator
HBB
RLMD
Relative Strength Index (RSI) 51.41 36.02
Support Level $18.43 $3.22
Resistance Level $39.99 $4.44
Average True Range (ATR) 1.89 0.19
MACD -0.45 0.00
Stochastic Oscillator 11.65 43.04

Price Performance

Historical Comparison
HBB
RLMD

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products segment includes consumer product revenue consisting of sales of small electric household and specialty housewares appliances whereas the health segment includes lease revenue associated with leases of connected devices to specialty pharmacy networks and pharmaceutical companies, as well as licensing revenue which grant customers the right to use software for healthcare management.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: